If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.
| TUMOUR GROUP/SITE | TRIAL SUMMARY | OPENING DATE |
|---|
BREAST
| RT CHARM: Testing the Safety and Breast Cancer Patient Experience of Short Course Radiation after Mastectomy and Breast Reconstruction (MAC.23) | May 2019
|
| A randomized trial of
regional radiotherapy in biomarker low risk node positive breast cancer (MA.39) | Oct 2018 |
| Randomized phase III trial
evaluating the role of weight loss in adjuvant treatment of overweight and
obese women with early breast cancer (BWEL MAC.20)
| Mar 2018
|
| CENTRAL NERVOUS SYSTEM (CNS) | A phase III trial of marizomib in combination
with standard temozolomide-based radiochemotherapy versus standard
temozolomide-based radiochemotherapy alone in patients with newly diagnosed
glioblastoma (CE.8) | Jun 2019 |
| GASTROINTESTINAL (GI) | | |
| GENITOURINARY (GU) - Prostate | A Phase 3 Randomized Study of Niraparib in
Combination with Abiraterone Acetate and Prednisone for Treatment of
Metastatic Prostate Cancer (MAGNITUDE)
| May 2019 |
| Androgen Suppression with Stereotactic Body or External Beam Radiation Therapy: A Phase II randomized trial for intermediate and high risk prostate cancer (ASSERT) | Apr 2016
|
GENITOURINARY (GU) - Kidney
| | |
| GENITOURINARY (GU) - Bladder |
| |
| GYNE - Ovary |
|
|
| HEAD AND NECK |
| |
LUNG
| Focused radiation therapy
for patients with early lung cancer near the important organs (SUNSET)
| Jun 2019 |
| LYMPHOMA |
|
|
| MELANOMA |
| |
| SARCOMA | | |
| SUPPORTIVE / PALLIATIVE CARE | | |
| SYMPTOM MANAGMENT | A randomized phase II/III
study comparing Stereotactic Body Radiotherapy (SBRT) versus conventional
palliative radiotherapy (CRT) for subjects with spinal metastases
(SC24)
| Nov 2017
|
| MULTI SITE | Phase II non-randomized trial of Stereotactic Ablative Radiotherapy (SABR) for Oligometastases (SABR-5) | Jan 2017 |
|
|
|
